 |
|
|
 |
St. John's Wort Controversy
A new clinical study on the popular herb St. John's wort is being published this week in the Journal of the American Medical Association, according to a press release from JAMA. The study reportedly shows that St. John's Wort (SJW) is not effective in treating severe cases of depression. more
|
|
FDA Approves Paxil (Paroxetine) For The Treatment of Generalized Anxiety Disorder
GlaxoSmithKline today announced that the U.S. Food and Drug Administration (FDA) approved Paxil(R) (paroxetine HCl) for the treatment of generalized anxiety disorder (GAD), making it the first and only selective serotonin reuptake inhibitor (SSRI) approved for this disorder. In the US GAD affects more than 10 million Americans, 60% of whom are women. GAD is a debilitating, chronic condition characterized by excessive anxiety and worry about a number of events or activities. Despite its prevalence and severity, only one third of sufferers receive treatment. Paxil is currently indicated for the treatment of depression, panic disorder, obsessive compulsive disorder and social anxiety disorder and is the number one prescribed SSRI in terms of new prescriptions. more
|
|
|
|
Smoking By Parents Reduces Vitamin C Levels In Children
Vitamin C can reduce the risk of heart disease and other illnesses, a new British study shows, while another study has found that children exposed to passive smoking in the home have lower levels of Vitamin C in their bloodstream. more
|
|
Contraceptives Offer Women No Protection From Pelvic Inflammatory Disease (PID)
Contraception does not reduce a woman's risk of pelvic inflammatory disease (PID), according to a study led by the University of Pittsburgh Graduate School of Public Health. The results are published in the May issue of Epidemiology. more
|
|
New Treatment Option For Ashtma Available As Of 16 April 2001
A new asthma treatment available in the US starting yesterday may change the way many of the 17 million Americans with asthma manage their condition. Advair Diskus (fluticasone propionate and salmeterol inhalation powder) is the first product that allows people to effectively treat the two main components of asthma, inflammation and bronchoconstriction, with one easy-to-use device. more
|
|
|
